Abstract: A sample holder includes a main component comprising a first surface area, and a retaining mechanism comprising a holding component. The retaining mechanism is configured to retain a sample between the holding component of the retaining mechanism and the first surface area in a closed state of the retaining mechanism. The retaining mechanism is further configured to enter an opened state upon mechanical actuation of the retaining mechanism. The opened state allows insertion and removal of the sample. The retaining mechanism is further configured to revert to the closed state once the mechanical actuation is removed.

Abstract: The invention relates to a sample transfer device (10) for reception of a sample, having a transfer rod (4) that is configured for reception of a sample holder, the sample holder to be arranged in a chamber (1) of the sample transfer device (10) for the purpose of transferring the sample to a processing unit or analytical unit (200), at least one measurement device (3, 8) for measuring a physical variable being arranged inside the sample transfer device (10).

Abstract: The invention relates to a sample transfer device (10) for reception of a sample, having a transfer rod (4) that is configured for reception of a sample holder, the sample holder to be arranged in a chamber (1) of the sample transfer device (10) for the purpose of transferring the sample to a processing unit or analytical unit (200), at least one measurement device (3, 8) for measuring a physical variable being arranged inside the sample transfer device (10).

Abstract: The present invention relates to 1-[m-carboxamido(hetero)aryl-methyl]-heterocycyl-carboxamide compounds of formula (I) wherein X, Ar1, R1, R2, R3, R4, R5a, R5b and p are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as CXCR7 receptor modulators.

Abstract: The present invention relates to 1-[m-carboxamido(hetero)aryl-methyl]-heterocycyl-carboxamide compounds of formula (I) wherein X, Ar1, R1, R2, R3, R4, R5a, R5b and p are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as CXCR7 receptor modulators.

Abstract: The invention relates to a solid oxide fuel cell system, wherein planar fuel cells are arranged in stacked form and in this respect an integrated post-combustion of non-oxidized components, or of not fully oxidized components, in the exhaust gas can take place. The fuel cells of a system in accordance with the invention have a cathode-electrolyte-anode unit. A bipolar plate is arranged between two respective fuel cells and channels for the supply and removal of a fuel gas to anodes and of an oxidizing agent to cathodes are present. The exhaust gases at the anode side or at the cathode side are introduced via internal additional channels or directly into an afterburner in which a catalytic post-oxidizing of the exhaust gas mixture formed with the exhaust gas at the anode side and at the cathode side takes place.

Abstract: The invention relates to a high-temperature fuel cell system having a start burner. Such fuel cell systems are in particular operated at temperatures between 650° C. and 1000° C. due to the ion-conductive properties of the electrolytes used. It is necessary for this reason to carry out a heating before the actual operation of the systems, which takes place by an external supply of energy. The exhaust gas of a start burner of the high-temperature fuel cell system is supplied to a heat exchanger or to two heat exchangers in a series connection for the preheating of an oxidizing agent which can be supplied to at least one fuel cell at the cathode side.

Abstract: Systems and methods are provided for switching collaborative applications. An example method comprises executing a first communication device and a second communication device associate with at least one contact, receiving an instruction to continue the collaborative session using the selected collaborative application that is different from the first collaborative application, determining whether the at least one contact is capable of continuing the collaborative session using the selected collaborative application, and terminating the first collaborative application.

Abstract: Systems and methods are provided for processing electronic messages for display in electronic devices. The method comprises receiving a message, detecting a language of the message, and based on the detected language updating local-language parameters. Thereafter, when the received message is displayed, additionally displayed information is updated based on the local-language parameters.

Abstract: The invention relates to a cooling apparatus (101) for a sample in an ion beam etching process, including, a sample stage (102) for arranging the sample, a coolant receptacle (120) containing a coolant, at least one thermal conduction element (106a, 106b) that connects the sample stage (102) to the coolant, a cooling finger (105) connected to the thermal conduction element (106a, 106b), the cooling finger (105) comprising a conduit (130, 131) through which coolant can flow and which is connectable to the coolant receptacle (120). The invention further relates to a method of adjusting the temperature of a sample in an ion beam etching process, including mounting a sample on a coolable sample stage (102), aligning the sample on the sample stage (102), and cooling the sample by coolant directed through a conduit (130, 131) of a cooling finger.

Abstract: The present invention relates to 1-[m-Carboxamido(hetero)aryl-methyl]-piperidine-4-carboxamide derivatives of formula (I) wherein X, Ar1, R1, R2, R3, R4, R5 and p are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as CXCR7 receptor modulators.

Abstract: A sample stage for processing a sample in an ion beam etching apparatus has positioning arrangements each having a receiving apparatus and a mask, a sample being mountable in the receiving apparatus with reference to an ion beam and positionable relative to the mask. The sample stage includes a mechanism that enables a switchover between respective positioning arrangements so a selected positioning arrangement is respectively orientable toward the ion beam. The sample in the selected positioning arrangement is exposed to the ion beam while the remaining positioning arrangements face away from the ion beam. The positioning arrangements are arranged in one common vessel. A method for sequential preparation of at least two samples in an ion beam etching unit using the sample stage is also disclosed.

Abstract: The invention relates to a solid oxide fuel cell system, wherein planar fuel cells are arranged in stacked form and in this respect an integrated post-combustion of non-oxidized components, or of not fully oxidized components, in the exhaust gas can take place. The fuel cells of a system in accordance with the invention have a cathode-electrolyte-anode unit. A bipolar plate is arranged between two respective fuel cells and channels for the supply and removal of a fuel gas to anodes and of an oxidizing agent to cathodes are present. The exhaust gases at the anode side or at the cathode side are introduced via internal additional channels or directly into an afterburner in which a catalytic post-oxidizing of the exhaust gas mixture formed with the exhaust gas at the anode side and at the cathode side takes place.

Abstract: The invention relates to a high-temperature fuel cell system having a start burner. Such fuel cell systems are in particular operated at temperatures between 650° C. and 1000° C. due to the ion-conductive properties of the electrolytes used. It is necessary for this reason to carry out a heating before the actual operation of the systems, which takes place by an external supply of energy. The exhaust gas of a start burner of the high-temperature fuel cell system is supplied to a heat exchanger or to two heat exchangers in a series connection for the preheating of an oxidizing agent which can be supplied to at least one fuel cell at the cathode side.

Abstract: A sample stage for processing a sample in an ion beam etching apparatus has positioning arrangements each having a receiving apparatus and a mask, a sample being mountable in the receiving apparatus with reference to an ion beam and positionable relative to the mask. The sample stage includes a mechanism that enables a switchover between respective positioning arrangements so a selected positioning arrangement is respectively orientable toward the ion beam. The sample in the selected positioning arrangement is exposed to the ion beam while the remaining positioning arrangements face away from the ion beam. The positioning arrangements are arranged in one common vessel. A method for sequential preparation of at least two samples in an ion beam etching unit using the sample stage is also disclosed.

Abstract: The invention relates to a cooling apparatus (101) for a sample in an ion beam etching process, including, a sample stage (102) for arranging the sample, a coolant receptacle (120) containing a coolant, at least one thermal conduction element (106a, 106b) that connects the sample stage (102) to the coolant, a cooling finger (105) connected to the thermal conduction element (106a, 106b), the cooling finger (105) comprising a conduit (130, 131) through which coolant can flow and which is connectable to the coolant receptacle (120). The invention further relates to a method of adjusting the temperature of a sample in an ion beam etching process, including mounting a sample on a coolable sample stage (102), aligning the sample on the sample stage (102), and cooling the sample by coolant directed through a conduit (130, 131) of a cooling finger.

Abstract: An apparatus for combining under sterile conditions a liquid component held in a first container and a solid or liquid component held in a second container is provided. In one embodiment, two hollow bodies for receiving the two containers are provided, the two hollow bodies being arranged one within the other and being slidable relative to one another in a guided manner in the longitudinal direction. A cannula holder forms a pot-shaped structural unit with the first hollow body. Alternatively, the cannula holder is provided with at least one cannula. The cannula holder and the first hollow body may be separate components, in which the cannula holder is pot-shaped.

Abstract: The invention develops an apparatus and a method for influencing the sleep of a person.

Abstract: The invention relates to pyrido[3,2-e]pyrazines, to processes for preparing them, to pharmaceutical preparations which comprise these compounds and to the pharmaceutical use of these compounds, which are inhibitors of phosphodiesterase 10, as active compounds for treating diseases of mammals including a human which can be influenced by using the compounds according to the invention to inhibit phosphodiesterase 10 activity in the central nervous system. More particularly, the invention relates to the treatment of neurologic and psychiatric disorders, for example psychosis and disorders comprising cognitive deficits as symptoms.

Abstract: The invention relates to pyrido[3,2-e]pyrazines, to processes for preparing them, to pharmaceutical preparations which comprise these compounds and to the pharmaceutical use of these compounds, which are inhibitors of phosphodiesterase 10, as active compounds for treating diseases of mammals including a human which can be influenced by using the compounds according to the invention to inhibit phosphodiesterase 10 activity in the central nervous system. More particularly, the invention relates to the treatment of neurologic and psychiatric disorders, for example psychosis and disorders comprising cognitive deficits as symptoms.